期刊文献+

阿维巴坦合成工艺改进 被引量:6

Improved synthesis of avibactam
原文传递
导出
摘要 目的改进阿维巴坦的合成方法。方法以(S)-1-(苄氧羰基)-5-氧代吡咯烷-2-羧酸为起始原料,经亲电加成、亲核取代、环化、还原、脱Cbz、酰化保护、亲核取代、脱保护、分子内脲化、水解、氨解、脱苄基、磺酸酯化、成盐、离子交换共13步反应得到阿维巴坦的钠盐,并优化各步反应条件。结果与结论优化后的工艺路线具有收率高、步骤少、操作简便、适合大量制备等优点,13步反应总收率为30.6%[以(S)-1-(苯甲氧基羰基)-5-酮基吡咯啶-2-羧酸计]终产品HPLC纯度99.5%。 To improve the synthetic process of avibactam,a β-lactamase inhibitor,was prepared from(S)-1-(benzyloxycarbonyl)-5-oxopyrrolidine-2-carboxylic acid through thirteen steps,including the electrophilic addition,nucleophilic substitution,cyclization,reduction,de-Cbz,acylation protection,nucleophilic substitution,deprotection,intramolecular urea formation hydrolysis,ammonolysis,debenzylation,sulfonate,salt formation and ion exchange.The target compound was synthesized with the overall yield of 30.6%[calculated from(S)-1-(benzyloxycarbonyl)-5-oxopyrrolidine-2-carboxylic acid].The improved process with high yield and less steps is easy to operate and suitable for large scale preparation.
出处 《中国药物化学杂志》 CAS CSCD 2016年第4期297-302,共6页 Chinese Journal of Medicinal Chemistry
基金 重大新药创制国家科技重大专项(2014ZX09507009021)
关键词 Β-内酰胺酶抑制剂 阿维巴坦 合成 工艺改进 β-lactamase inhibitors avibactam synthesis process improvement
  • 相关文献

参考文献6

  • 1US FDA. FDA approves new antibacterial drug Avy- caz[ EB/OL ]. [ 2014 - 02 - 25 ]. http ://www. fda. gov/new sevents/new sroom/pressannouncements/ ucm435629, htm.
  • 2郁群,董金华.头孢他啶-阿维巴坦[J].中国药物化学杂志,2015,25(5):413-413. 被引量:11
  • 3ABE T, OKUE M, SAKAMAKI Y. Optically-activediazabicyclooctane derivative and method for manu- facturin same :2012086241 [ P]. 2012 - 06 - 28.
  • 4MAX/ME L, JOZSEF A, DVID A R. Azabicyclic compounds, preparation thereof and as medicines, in particular as antibacterial agents: 711259 [ P ]. 2006 - 09 - 26.
  • 5MAXIME L, JOZSEF A, DVID A R. Heterocyclic compounds as inhibitors of beta-lactamases:7612087 [ P ]. 2009 - 11 - 03.
  • 6MELANIE S R, SAIBABA R, SHAO H Z. Processes for preparing heterocyclic compounds including trans- 7-oxo-6-( sulphooxy ) -1,6-diazabicyclo [ 3.2. 1 ] oc- tane-2-carboxamide and salts thereof: 20140163230 [P]. 2014 -06 - 12.

二级参考文献4

  • 1US FDA. FDA approves new antibacterial drug Avycaz[- EB/ OL]. [ 2014 - 2 - 25 ]. http://www, fda. gov/newseventsd newsroom/pressannouncements/ucm435629, htm.
  • 2ABE T, OKUE M, SAKAMAKI Y. Optically-active diazabi- cyclooctane derivative and method for manufacturing same: WO ,2012086241 [ P]. 2012 - 06 - 28.
  • 3LAI-IIRI S D, MANGANI S, DURAND-REVILLE T, et al. Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and pseudomonas aeruginosa AmpC beta-lac- tamases [ J ]. Antimicrob Agents Chemother, 2013,57 ( 6 ) : 2496 - 2505.
  • 4VAZQUEZ J A, GONZALEZ PATZAN L D, STRICKLIN D,et al. Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a .prospective, investigator-blinded, rando- mized study[ J]. Cuff Med Res Opin, 2012,28 ( 12 ) : 1921 - 1931.

共引文献10

同被引文献12

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部